Dr Reddy's Open To Making Pfizer Covid Pill
NDTV
Dr Reddy's managing director G.V. Prasad said the pharma major had not yet initiated any talks with Pfizer before the US company sought regulatory permissions.
Dr Reddy's Laboratories, one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said on Monday it was open to making a similar pill from Pfizer, thought to be even more effective.
The new drugs, which unlike vaccines can be used to treat patients once they contract coronavirus infection, are expected to be a huge market. Merck has given out licenses to manufacturers in developing countries to ensure a swift global supply, and companies are hopeful that Pfizer will do the same.
"Yeah, yeah, absolutely," Dr. Reddy's co-chairman and managing director, G.V. Prasad, told Reuters in an interview, when asked about making rival products from the US companies.
"Dr. Reddy's remains open to all opportunities," a company spokesperson said separately.
